Table 2.
Clinical and radiographic success rates of BiodentineTM and formocresol groups at 3–, 6–, and 12–month
| Assessment | 3 months n (%) | 6 months n (%) | 12 months n (%) | P of McNemar’s test (3/6 to 12 months) | |
|---|---|---|---|---|---|
| Clinical | BiodentineTM | 56/ 56 (100) | 56/ 56 (100) | 54/ 54 (100) | - |
| Formocresol | 56/ 56 (100) | 56/ 56 (100) | 54/ 54 (100) | - | |
| P of Fisher exact test | - | - | - | ||
| Radiographic | BiodentineTM | - | 56/ 56 (100) | 54/ 54 (100) | - |
| Formocresol | - | 56/ 56 (100) | 53/ 54 (98.1) | 1.00 | |
| P of Fisher exact test | - | - | 1.00 | ||
Clinically, at all follow–up periods and radiographically at 6 and 12 months in both groups, all cases were successful, and no test was computed